29 results
424B3
07gdakh qu03342m3z
4 Apr 23
Prospectus supplement
4:57pm
POS AM
yhlcyk6pjar7 2zzbf
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
PRE 14A
r611kifojg99b0
21 Apr 22
Preliminary proxy
4:33pm
424B4
x7o4h r8trm
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
4qcff95c524cehe
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
wp0e01kg20
2 Jun 21
Draft registration statement
12:00am
DRS
0evg7z079d y4
2 Jun 21
Draft registration statement
12:00am
DEFA14A
ebr v6zde
30 Apr 21
Additional proxy soliciting materials
5:21pm
DEF 14A
iokq8c1c038e0z2nop
30 Apr 21
Definitive proxy
5:20pm
10-K
lkwfy3 v4ew5gv
31 Mar 21
Annual report
2:14pm